| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.0071 | 0.8 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.04 | 0.8 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.8 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.8 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.9 |
| mRNA | AZD-2281 | FIMM | pan-cancer | AAC | 0.037 | 0.9 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.014 | 0.9 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.0083 | 0.9 |